An 'extraordinary' new class of drugs are set to undergo human trials after researchers believe they could become the first ...

Current approaches in bioengineering are synthesized and methods for their implementation are suggested for the induction and modulation of trained immunity in the treatment of human diseases.

In a major stride toward tackling aggressive breast cancer, researchers from The Hebrew University of Jerusalem have developed druglike molecules that degrade a previously "undruggable" cancer-driving ...

In the battle against aggressive breast cancer, a once-elusive target is now within reach—thanks to a breakthrough from a ...

Small molecule drugs are low-molecular-weight, organic compounds used to treat a wide range of conditions. Here's what you should know.

Colon cancer is often driven by cancer stem cells, which resist treatment and lead to relapse. In a recent study, researchers ...

Scientists have uncovered a molecular "on–off" switch that helps lung adenocarcinoma—the most common form of lung cancer—grow ...

Around 10 million people globally live with the life-threatening virus HTLV-1. Yet it remains a poorly understood disease ...

PhoreMost Ltd., a next-generation targeted protein degradation (TPD) company progressing a pipeline of degrader therapeutics within oncology and inflammation, today announced the publication of a ...

Classical psychedelics like LSD, psilocybin, and mescaline are known for activating the 5-HT2A serotonin receptor, but a new ...

Scientists have studied a new target for antibiotics in the greatest detail yet—in the fight against antibiotic resistance. The "molecular machine" flagellum is essential for bacteria to cause ...